Pamela Mongelos

Pamela Mongelos

Auto-generated profile, based on publicly available information

Pamela Mongelos

Health Sciences Research Institute (IICS) , National University of Asuncion (UNA) , San Lorenzo , Paraguay

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LMLaura Mendoza
Laura Mendoza
PMPamela Mongelos
Pamela Mongelos
MPMalvina Paez
Malvina Paez
ACAmalia Castro
Amalia Castro
IRIsabel Rodriguez-Riveros
Isabel Rodriguez-Riveros
MPMaría Alejandra Picconi
María Alejandra Picconi
The incidence of cervical cancer in Paraguay is among the highest in the world, with the human papillomavirus (HPV) being a necessary factor for cervical cancer. Knowledge about HPV infection among indigenous women is limited. This cross-sectional study analyzed the frequency of HPV and other genital infections in indigenous Paraguayan women of the Department of Presidente Hayes.

1 October 2015 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PMPamela Mongelos
Pamela Mongelos
LMLaura Mendoza
Laura Mendoza
IRIsabel Rodriguez-Riveros
Isabel Rodriguez-Riveros
ACAmalia Castro
Amalia Castro
GGGraciela Gimenez
Graciela Gimenez
MPMaría Alejandra Picconi
María Alejandra Picconi
Objective: To determine the frequency of human papillomavirus (HPV) types and to assess bacterial vaginosis (BV) possible associations with cervical infections in indigenous Paraguayan women of the Department of Presidente Hayes. Methods: This study included 181 sexually active women without cervical lesions. HPV typing was performed by polymerase chain reaction with primers PGMY 09/11 followed by reverse line hybridization. BV was diagnosed by the Nugent criteria using the results from a Gram stain smear. Results: Sixteen percent of women were positive for at least one high risk HPV type (HR-HPV). The most frequent genotypes were HPV 16 (4.4%), followed by HPV 58 (3.3%), HPV 45 (3.3%), HPV 53 (2.8%) and HPV 11 (2.8%). A significant association between HR-HPV and BV was observed (p=0.01). In addition, women with BV had a higher frequency of Chlamydia trachomatis (p=0.0007), Trichomonas vaginalis (p=0.00009), Mycoplasma hominis (p=0.001). Conclusions: A large variety of HPV genotypes was detected and showed a slightly different pattern from previous studies on urban women in Paraguay, with the predominance of HR-HPV. Furthermore, the information of co-infections involved in BV could be useful for the improvement of national prevention programs, as well as for laboratory surveillance of these genital infections. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.

29 October 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAlanis Arévalos
Alanis Arévalos
AVAdriana Valenzuela
Adriana Valenzuela
PMPamela Mongelós
Pamela Mongelós
HBHernán Barrios
Hernán Barrios
MRMaría Isabel Rodríguez
María Isabel Rodríguez
EGESTAMPA Paraguayan Study Group
ESTAMPA Paraguayan Study Group
Objective: To determine the prevalence of genital infections (GIs), including sexual transmitted STIs: Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, and opportunistic pathogens that generally do not cause STIs, non-classic STI: Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma hominis, in women with high-risk oncogenic human papillomavirus (hr-HPV) infection and their association with cervical lesions. Methods: A cross-sectional study was carried out including 231 hr-HPV positive women. Of these, 46 has histologically confirmed cervical intraepithelial neoplasia 3 (CIN3) or more (including CIN3 and cervical cancer lesions-CIN3+). GIs were detected by multiplex real time PCR. Odds ratios (OR) were estimated to explore possible associations between GIs and the presence or absence of CIN3+ lesions. Additionally, we examined associations between sociodemographic, sexual, and clinical characteristics and the presence of GIs. Results: In total, there were 174/231 cases of GIs corresponding to an overall prevalence of 75.3% (95%CI: 69.4–80.4), being non-classic STIs the most common (72.3%) compared to STIs (12.6%). The most prevalent non-classic STI and STI were U. parvum (49.8%) and C. trachomatis (7.4%), respectively. The odds of presenting GIs were 3 times higher in women under 46 years compared to older counterparts (OR: 3.32, 95%CI: 1.74–6.16), and in women with a normal Pap smear with inflammation compared to those without inflammation (OR: 3.31, 95%CI: 1.15–9.77). GIs were equally present in women with and without CIN3+ lesions. Conclusion: We observed an association of GIs with inflammation in the Pap smear, but no association with CIN3+, as some of them are very common and likely part of the normal vaginal flora, suggesting that such infections do not appear to be cofactors in cervical carcinogenesis, although larger prospective studies are needed.

1 January 2026 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
PMPamela Mongelós
Pamela Mongelós
MMMagaly Martínez
Magaly Martínez
NDNatalia Díaz
Natalia Díaz
VNValéria Talpe Nunes
Valéria Talpe Nunes
AVAdriana Valenzuela
Adriana Valenzuela
LMLaura Mendoza
Laura Mendoza
Human papillomavirus Type 16 (HPV16) variants are classified into four lineages (A–D) and 16 sublineages: A1–3 (European), A4 (Asian), B1–4 and C1–4 (African), and D1–4 (Asian‐American). This study investigated the genetic HPV16 variability through sequencing of the complete long control region (LCR), in 44 cervical samples from Paraguayan women, including 19 without cervical intraepithelial neoplasia grade 2 (<CIN2) and 25 with CIN2 or worse (CIN2+: 1 CIN2, 16 CIN3, and 8 invasive cancers). Sublineages A1 (81.8%), A4 (2.3%), D2 (2.3%), D3 (11.4%), and D4 (2.3%) were detected. A total of 48 point mutations were detected, of which 11 showed nominal association with CIN2+ ( p < 0.05), although none remained statistically significant after correction for multiple comparisons. Notably, most of these mutations were predominantly observed in non‐A1–A3 variants. An exploratory association was observed between non‐A1–A3 variants and the presence of CIN2+ ( p = 0.0065). Functional analysis revealed that the A4 variant, detected in a woman with cancer, exhibited the highest transcriptional activity (2.34 ± 0.78), followed by D3 (0.72 ± 0.21) and A1 (0.03 ± 0.02), corresponding to samples from women with CIN3 and without lesions, respectively. In conclusion, we report for the first time the detection of an A4 HPV16 variant in Paraguay, which exhibited the highest transcriptional activity among the variants analyzed. These findings suggest potential functional differences among HPV16 variants and are consistent with a possible relevance of non‐A1–A3 variants in cervical lesion severity. However, these results should be interpreted with caution as exploratory and hypothesis‐generating.